Ann: Positive clinical data reported at breast cancer symposium, page-104

First 104 Last

Share
Profile

Follow
Looking4ideas

229 Posts.

108

13/12/22

21:09

Post #: 65299611
Share

Originally posted by HighDesert: ↑

Thanks for taking the time translate the halftime score, LOL
IBX5
Cancer Evasion0

1. Very fortunate to make the "Annual SABCS submission deadline", and gain industry exposure.
2. Excellent "halftime adjustment" - Based on the learnings from the first six subject data, we amended the protocol to improve the data collection.3. A leap forward when you can eliminate "Radiologist subjectivity" or "Operator Error" out of the analysis. What we are seeing in the study is that by using the MagSense® nanoparticles the radiologist can still get the standard size/shape assessment but also gets added information that comes from the change in contrast (darkening of the image) resulting from the nanoparticles when they become attached to tumor cells (the “molecular signature”). The amount of contrast is different if the node is “normal” vs when tumor cells are present. The conclusion being that a test with a molecular imaging agent could provide better radiological assessment and improve on the current clinical standard of care.
This is exactly the use we have been aiming for. Rather than use imaging to identify a “region of interest” or “suspicious lesion”, use a molecularly targeted approach to determine if, in fact, cancer cells are present.4.The goal of our Phase I study has been to bridge the gap between our pre-clinical studies and human biology. The data we have accumulated to-date recapitulates in human subjects what we found in our preclinical workups –that our imaging agent is detectable, andthe imaging signature helps differentiate when cancer cells are present.
5. Good call on using available funds in a prudent manner, holding off on developing the human sized Magsense Detector until there has been ascertainable data that the existing small animal MRX can verify its effectiveness in this FIH trials.
We have reported that for those patients where we have obtained sufficient tissue,there is a measurable MRX signal,indicating detectability, but we feel we need more samples/data before being able to draw any conclusions that would result in commitment of investment in developing the instrument system.

Expand

innovation is 90% implementation, not just having a good idea

imagion are failing spectacularly at implementation

your pandering is nauseating

you are obviously knowledgeable and analytical, but unfortunately not commercial

IBX Price at posting: 2.7¢ Sentiment: Hold Disclosure: Held
6 Upvote

1 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASM

ASM to push Dubbo REE play towards economical production with A$5M Federal govt grant

A1G

African Gold finds significant 5.5g/t intercept over 65m in Cote d’Ivoire

Wealth Within: the latest stock tips from Dale Gillham

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

There are more pages in this discussion • 7 more messages in this thread...

First 104 Last

Add IBX (ASX) to my watchlist

(20min delay)
Last 3.6¢		Change 0.003(9.09%)		Mkt cap ! $1.283M

Open	High	Low	Value	Volume
3.3¢	3.6¢	3.3¢	$882	25.26K

Buyers (Bids)

No.	Vol.	Price($)
2	46299	3.3¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	275207	1

View Market Depth

No.	Vol.	Price($)
2	46299	0.033
2	52777	0.031
2	104778	0.030
1	350000	0.029
5	315000	0.028

Price($)	Vol.	No.
0.036	275207	1
0.037	25000	1
0.040	70000	1
0.042	66460	1
0.047	14800	1

Last trade - 13.51pm 15/10/2024 (20 minute delay)

IBX (ASX) Chart

Ann: Positive clinical data reported at breast cancer symposium, page-104

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASM to push Dubbo REE play towards economical production with A$5M Federal govt grant

African Gold finds significant 5.5g/t intercept over 65m in Cote d’Ivoire

Wealth Within: the latest stock tips from Dale Gillham

Battery Age Minerals gets set to capitalise on critical mineral demand

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Positive clinical data reported at breast cancer symposium, page-104

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASM to push Dubbo REE play towards economical production with A$5M Federal govt grant

African Gold finds significant 5.5g/t intercept over 65m in Cote d’Ivoire

Wealth Within: the latest stock tips from Dale Gillham

Battery Age Minerals gets set to capitalise on critical mineral demand

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News